Anatara Lifesciences Ltd - Asset Resilience Ratio

Latest as of December 2024: 2.84%

Anatara Lifesciences Ltd (ANR) has an Asset Resilience Ratio of 2.84% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Anatara Lifesciences Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$50.00K

≈ $35.38K USD Cash + Short-term Investments

Total Assets

AU$1.76 Million

≈ $1.25 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Anatara Lifesciences Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Anatara Lifesciences Ltd.

Liquid Assets Composition Over Time

This chart breaks down Anatara Lifesciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Anatara Lifesciences Ltd (ANR) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$50.00K	2.84%
Total Liquid Assets	AU$50.00K	2.84%

Asset Resilience Insights

Limited Liquidity: Anatara Lifesciences Ltd maintains only 2.84% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Anatara Lifesciences Ltd Industry Peers by Asset Resilience Ratio

Compare Anatara Lifesciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Celldex Therapeutics Inc NASDAQ:CLDX	Biotechnology	81.32%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	Biotechnology	87.20%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Savara Inc NASDAQ:SVRA	Biotechnology	68.30%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%

Annual Asset Resilience Ratio for Anatara Lifesciences Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Anatara Lifesciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	3.00%	AU$50.09K ≈ $35.44K	AU$1.67 Million ≈ $1.18 Million	-0.53pp
2023-06-30	3.52%	AU$50.00K ≈ $35.38K	AU$1.42 Million ≈ $1.00 Million	+0.69pp
2022-06-30	2.83%	AU$50.00K ≈ $35.38K	AU$1.77 Million ≈ $1.25 Million	+1.67pp
2021-06-30	1.16%	AU$50.00K ≈ $35.38K	AU$4.33 Million ≈ $3.06 Million	--
2020-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.34 Million ≈ $2.37 Million	--
2019-06-30	63.46%	AU$4.05 Million ≈ $2.87 Million	AU$6.38 Million ≈ $4.52 Million	+0.27pp
2018-06-30	63.19%	AU$6.20 Million ≈ $4.39 Million	AU$9.81 Million ≈ $6.94 Million	-24.99pp
2017-06-30	88.17%	AU$10.86 Million ≈ $7.68 Million	AU$12.32 Million ≈ $8.71 Million	+34.74pp
2016-06-30	53.43%	AU$7.44 Million ≈ $5.26 Million	AU$13.92 Million ≈ $9.85 Million	-18.59pp
2015-06-30	72.03%	AU$4.05 Million ≈ $2.87 Million	AU$5.63 Million ≈ $3.98 Million	--

pp = percentage points

About Anatara Lifesciences Ltd

AU:ANR Australia Biotechnology

Market Cap

$1.57 Million

AU$2.23 Million AUD

Market Cap Rank

#30338 Global

#1775 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$1.64